Skip to main content
66°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.32
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
99
100
Next >
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports
February 19, 2025
Trump's proposed 25% tariffs on auto, semiconductor, and pharmaceutical imports have rattled markets and could affect ETFs with heavy exposure to these sectors.
Via
Benzinga
Topics
ETFs
Government
World Trade
Rule Breaker Investing Stock Stories, Vol. 10: Frosty Campfire, Fiery Stocks
February 19, 2025
Every stock tells a story; it takes humans to find the meaning in it.
Via
The Motley Fool
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields
February 19, 2025
Via
Benzinga
3 Things You Need to Know If You Buy Pfizer Today
February 18, 2025
Via
The Motley Fool
Are Investors Being Too Paranoid About Pfizer Stock?
February 13, 2025
Via
The Motley Fool
Pfizer's Options Frenzy: What You Need to Know
February 11, 2025
Via
Benzinga
Love, Money, and Stocks
February 18, 2025
Via
The Motley Fool
Which S&P500 stocks are the most active on Tuesday?
February 18, 2025
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest...
Via
Chartmill
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.’s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE)
February 18, 2025
From
Berger Montague
Via
GlobeNewswire
Trump's Tax Cut Could Add $4.6 Trillion To Deficit, With $48 Billion Tax Relief For Top 100 Firms: Robert Reich
February 18, 2025
Robert Reich has termed Donald Trump's taxation policies as an "absolutely shameless giveaway," that could shoot up deficit to $4.6 trillion.
Via
Benzinga
Topics
Government
Health Insurance ETFs in Focus as RFK Jr Takes Over HHS
February 17, 2025
Robert F. Kennedy Jr. has taken office as HHS secretary, which could impact the healthcare sector, including ETFs with exposure to insurers like UnitedHealth and Elevance Health.
Via
Benzinga
Topics
ETFs
Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors
February 17, 2025
Ken Griffin's Citadel hedge fund places £305M short bet against GSK, with skepticism over long-term pipeline and recent stock rally.
Via
Benzinga
3 Magnificent Stocks to Buy That Are Near 52-Week Lows
February 17, 2025
Via
The Motley Fool
Pfizer's Talzenna/Xtandi Combo Improves Survival Outcomes In Metastatic Castration-Resistant Prostate Cancer
February 14, 2025
Pfizer's TALAPRO-2 study shows Talzenna + Xtandi significantly improves survival in mCRPC patients, with up to a 14-month OS gain in HRR-mutated cases.
Via
Benzinga
Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump's Secretary Of Health: Health Care Stocks To Watch
February 13, 2025
The U.S. Senate voted on Thursday to confirm President Donald Trump's nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Via
Benzinga
Topics
Government
Pfizer’s TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic Castration Resistant Prostate Cancer
February 13, 2025
From
Pfizer Inc.
Via
Business Wire
Zoetis (NYSE:ZTS) Posts Q4 Sales In Line With Estimates But Stock Drops
February 13, 2025
Animal health company Zoetis (NYSE:ZTS) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.7% year on year to $2.32 billion. On the other hand, the company’s full-year revenue...
Via
StockStory
3 Brand-Name, Ultra-High-Yield Dividend Stocks Patient Investors Can Confidently Buy With $300 Right Now
February 13, 2025
A trio of high-octane income stocks -- sporting an average yield of 6.65% -- can fatten investors' pocketbooks in 2025 (and well beyond).
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
February 12, 2025
Via
Benzinga
U.S. FDA Approves Pfizer’s ADCETRIS® Combination Regimen for the treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
February 12, 2025
From
Pfizer Inc.
Via
Business Wire
Earnings To Watch: Zoetis (ZTS) Reports Q4 Results Tomorrow
February 12, 2025
Animal health company Zoetis (NYSE:ZTS) will be reporting results tomorrow before market open. Here’s what to look for.
Via
StockStory
Organon (OGN) Q4 Earnings Report Preview: What To Look For
February 12, 2025
Pharmaceutical company Organon (NYSE:OGN) will be reporting earnings tomorrow before market hours. Here’s what investors should know.
Via
StockStory
Pfizer/Astellas Tout Encouraging Data From Keytruda Combo Regime In Urothelial Cancer Showing 49% Reduction In Death Risk Vs. Chemo
February 11, 2025
Pfizer and Astellas' Padcev-Keytruda combo showed durable survival benefits in urothelial cancer, with a higher response rate and no new safety concerns.
Via
Benzinga
Pfizer and Astellas’ PADCEV® (enfortumab vedotin-ejfv) plus KEYTRUDA® (pembrolizumab) Shows Long-Term Efficacy in First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer (la/mUC)
February 10, 2025
From
Pfizer Inc.
Via
Business Wire
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session.
February 10, 2025
Let's have a look at what is happening on the US markets on Monday. Below you can find the most active S&P500 stocks in today's session.
Via
Chartmill
Super Bowl Commercials 2025: Complete List of Super Bowl LIX Ads And Companies Behind Them
February 10, 2025
The list of Super Bowl LIX commercials and the companies behind the Super Bowl ads.
Via
Benzinga
These Stocks Missed on Earnings, But Will Rebound Next Quarter
February 10, 2025
Here are three stocks from companies that missed on earnings but have strong support from analysts that makes each stock a solid Buy for the next year
Via
MarketBeat
Royalty Pharma Earnings: What To Look For From RPRX
February 10, 2025
Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) will be reporting earnings tomorrow morning. Here’s what to look for.
Via
StockStory
Better High-Yield Dividend Stock: Pfizer vs. Merck
February 10, 2025
Via
The Motley Fool
3 No-Brainer Healthcare Stocks to Buy With $200 Right Now
February 10, 2025
Via
The Motley Fool
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.